In order to study the mechanism of hypoglycemic action of ginsenoside-Rb2 in diabetic rats, experiments were performed to determine carbohydrate metabolites and the levels of lipid constituents. The rats treated with ginsenoside-Rb2 showed a significant decrease of glucose in the hepatic tissue. The level of hepatic glycogen was slightly increased after ginsenoside-Rb2 administration. The glucose-6-phosphate level tended to increase, the pyruvate level was unchanged, and the lactate level tended to decrease. There was, however, no accumulation of total lipid in hepatic tissue. In rats given ginsenoside-Rb2, the levels of triglyceride, non-esterified fatty acid, 3-hydroxybutyrate, and acetoacetate were markedly decreased, showing a trend toward restoration of the normal state and inducing an increase in lipids in the adipose tissue. The hypoglycemic action of ginsenoside-Rb2 is discussed on the basis of the present results.
Results

Effect of Ginsenoside-Rb2 on Carbohydrate Metabolites in the Liver
Compared to non-diabetic rats, streptozotocin-induced diabetic rats exhibited a significant elevation of hepatic glucose, and a tendency toward an increase of pyruvate and lactate. The contents of glycogen and glucose-6-phosphate behaved differently from those of the other carbohydrate metabolites, decreasing by approximately 20% and 12%, respectively (Table I) . When ginsenoside-Rb2 was successively given at the dose of 10 mg once a day, the hepatic glucose content fell to 9.42 mg/tissue after 6 d of administration (significantly decreased by 27% of the control value). In contrast, administration of ginsenoside-Rb2 to rats slightly increased the amounts of glycogen and glucose-6-phosphate. These changes are in reciprocal relation to that of hepatic glucose content. However, pyruvate and lactate contents showed no appreciable changes when ginsenoside-Rb2 was administered. Table II shows the hepatic lipid constituent contents. A slight increase of the total lipid content was seen in streptozotocin-induced diabetic rats as compared with the non-diabetic Figures in parentheses are percentages of the non-diabetic or diabetic control value. *, significantly different from the non-diabetic or diabetic control value, p < 0.05, a) p < 0.01, b)**, p < 0.001. rats. This change was reflected in the triglyceride content; as shown in Table II , the triglyceride content in the liver was increased to 36.6 mg/tissue compared with 26.0 mg/tissue in normal rats. The data in Table II further indicate that the amount of phospholipid was decreased significantly as compared with non-diabetic rats, while it was remarkably high in the ginsenoside-Rb2-administered group. On the other hand, hepatic triglyceride was extremely low, at a near-normal level, in the ginsenoside-Rb2-administered group. Administration of ginsenoside-Rb2 to rats caused no appreciable changes of the total lipid and total cholesterol contents of the liver.
Effect of Ginsenoside-Rb2 on the Lipid Constituents in the Liver
Effect of Ginsenoside-Rb2 on the Lipid Constituents in the Adipose Tissue
As shown in Table III , the contents of lipid constituents were significantly decreased in streptozotocin-induced diabetic rats as compared with the non-diabetic rats, as follows: total lipid (40%), triglyceride (37%), and phospholipid (26%). A striking increase in total lipid and triglyceride contents was observed after 6 administrations of ginsenoside-Rb2. The phospholipid content also increased by 24% when ginsenoside-Rb2 was administered. However, nonesterified fatty acid showed no appreciable change. 
